Active	Status	Sponsor type	Region	Phase	Filter
6 Active 8 Inactive 14 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
L-4-chlorokynurenine (AV-101) / VistaGen
NCT04147949: AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia	Not yet recruiting	2	20	NA	AV-101, L-4-chlorokynurenine, Placebo	VistaGen Therapeutics, Inc.	Parkinson Disease, Dyskinesia, Medication-Induced, L-Dopa Causing Adverse Effects in Therapeutic Use	12/23	04/24
NCT05280054: AV-101 Alone and in Combination With Probenecid in Healthy Subjects	Recruiting	1	24	US	AV-101, 4-chloro-kynurenine, Probenecid	VistaGen Therapeutics, Inc., Parexel	Drug Drug Interaction	09/22	11/22
fasedienol (PH94B NS) / VistaGen
Palisade-2, NCT05011396: PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2	Terminated	3	324	US	PH94B Nasal Spray, Placebo Nasal Spray	VistaGen Therapeutics, Inc.	Social Anxiety Disorder	08/22	08/22
PALISADE-3, NCT06358651: Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder	Recruiting	3	236	US	Fasedienol Nasal Spray, Placebo Nasal Spray	VistaGen Therapeutics, Inc.	Social Anxiety Disorder	06/25	06/26
PALISADE-4, NCT06615557: Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder	Recruiting	3	236	US	Fasedienol Nasal Spray, Placebo Nasal Spray	VistaGen Therapeutics, Inc.	Social Anxiety Disorder (SAD)	10/25	10/26
NCT04404192: PH94B in the Treatment of Adjustment Disorder With Anxiety	Completed	2	41	US	PH94B, Aloradine, Placebo	VistaGen Therapeutics, Inc.	Adjustment Disorder With Anxious Mood	12/22	12/22
PH80 / VistaGen
No trials found